Skip to main content
. 2006 Sep 11;149(5):481–489. doi: 10.1038/sj.bjp.0706892

Figure 8.

Figure 8

(a) Western blot analysis of F656A and F656C mutations for control conditions and following 24 h incubation with 1 and 30 μM fluoxetine. (b) Plots of normalized peak tail IhERG (square pulse protocol) for WT, and the F656A and F656C mutations, for control conditions and following 1 or 30 μM fluoxetine exposure.